Tooth Mousse and Fluoride in Dentin Hypersensitivity Treatment
This study has been completed.
Sponsor:
Huazhong University of Science and Technology
Collaborator:
National Natural Science Foundation of China
Information provided by:
Huazhong University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00926484
First received: June 22, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | June 22, 2009 | ||||
| Last Updated Date | June 22, 2009 | ||||
| Start Date ICMJE | January 2007 | ||||
| Primary Completion Date | January 2008 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
ANOVA [ Time Frame: June 2008 ] [ Designated as safety issue: Yes ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE |
T-test [ Time Frame: June 2008 ] [ Designated as safety issue: Yes ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Tooth Mousse and Fluoride in Dentin Hypersensitivity Treatment | ||||
| Official Title ICMJE | Combined Tooth Mousse and Fluoride Varnish in Dentin Hypersensitivity Treatment | ||||
| Brief Summary | GC Tooth Mousse, a complex containing amorphous calcium phosphate (ACP) and casein phosphopeptide (CPP), is recommended in dentin hypersensitivity reduction due to its ability to block opened dentinal tubules. It acts synergistically with fluorine in slowing caries progression. Whether CPP-ACP can act synergistically with fluorine in the dentin hypersensitivity treatment is unknown. The aim of this study was to assess the effect of CPP-ACP combined with fluoride varnish in cervical dentin hypersensitivity treatment. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Retrospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Probability Sample | ||||
| Study Population | primary care clinic |
||||
| Condition ICMJE | Dentin Hypersensitivity | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) |
|
||||
| Publications * | Kowalczyk A, Botuli?ski B, Jaworska M, Kierklo A, Pawi?ska M, Dabrowska E. Evaluation of the product based on Recaldent technology in the treatment of dentin hypersensitivity. Adv Med Sci. 2006;51 Suppl 1:40-2. | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 30 | ||||
| Completion Date | June 2008 | ||||
| Primary Completion Date | January 2008 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 26 Years to 66 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | China | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00926484 | ||||
| Other Study ID Numbers ICMJE | TF87330244 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Weimin Chen, Tongji Hospital, Huazhong University of Science and Technology | ||||
| Study Sponsor ICMJE | Huazhong University of Science and Technology | ||||
| Collaborators ICMJE | National Natural Science Foundation of China | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Huazhong University of Science and Technology | ||||
| Verification Date | June 2009 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||